| Literature DB >> 31781622 |
Shihui Liu1, Youdong Hu2, Rongrong Tao1, Qingwei Huo1, Lin Wang1, Chunzhi Tang1, Changjiang Pan3, Tao Gong3, Nenggui Xu1, Tao Liu1.
Abstract
Vascular stent interventional therapy is the main method for clinical treatment of coronary artery diseases. However, due to the insufficient biocompatibility of cardiovascular materials, the implantation of stents often leads to serious adverse cardiac events. Surface biofunctional modification to improve the biocompatibility of vascular stents has been the focus of current research. In this study, based on the structure and function of extracellular matrix on vascular injury healing, a novel fibronectin-loaded poly-l-lysine/heparin nanoparticles was constructed for stent surface modification. In vitro blood compatibility evaluation results showed that the nanoparticles-modified surface could effectively reduce platelet adhesion and activation. In vitro cellular compatibility evaluation results indicated that the nanocoating may provide adequate efficacy in promoting the adhesion and proliferation of endothelial cells and thereby accelerate endothelialization. This study provides a new approach for the surface biological function modification of vascular stents.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31781622 PMCID: PMC6875231 DOI: 10.1155/2019/5478369
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Schematic drawing of fibronectin-loaded nanoparticles fabrication and immobilization.
Size and zeta potential of prepared nanoparticles.
| Zeta potential (mV) | Size (nm) | PDI | |
|---|---|---|---|
| NP | −27.3 ± 0.5 | 313 ± 19 | 0.102 ± 0.052 |
| NPF | −26.2 ± 1.4 | 287 ± 26 | 0.049 ± 0.011 |
Figure 2Surface chemical composition determined by FTIR spectra.
Figure 3Quantitative characterization result of amine group and heparin exposing density of different sample surfaces (mean ± SD, n = 6).
Figure 4Alteration of surface hydrophilicity during surface modification (mean ± SD, n = 6).
Figure 5Morphology of nanoparticles-modified surface determined by AFM.
Figure 6In vitro blood compatibility evaluation result. (a) Rhodamine 123 fluorescence staining of adhered platelets. (b) P-selectin semiquantitative characterization result (mean ± SD, n = 6; p < 0.05 indicates significant difference in comparison with 316L SS and SS-DA).
Figure 7(a) Rhodamine 123 and DAPI fluorescence staining of adhered ECs after culture of 1 and 3 days. (b) Cell proliferation activity detected by CCK-8. (c) Cell proliferation ratio from day 1 to 3. (mean ± SD, n = 12; p < 0.05 indicates significant difference).